Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of a High Dose of Erythropoietin Administered During Graft Processing for Early Graft Outcome in Kidney Transplant Recipients.

NCT01450878 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT01450878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01450878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of a High Dose of Erythropoietin Administered During Graft Processing for Early Graft Outcome in Kidney Transplant Recipients.
Lead sponsor
University Hospital, Limoges
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2011
Completion date
March 31, 2013
Enrollment
6 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

ischemia